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Correlations between the radiation dose to cochlear and sensorineural hearing loss in
head and neck cancer
INTRODUCTION: Intensity modulated radiotherapy(IMRT) is an advanced form of three
dimensional conformal radiotherapy using computer optimised inverse treatment planning
and a computer controlled multileaf collimator which safely deliver precise radiation dose to
tumour while minimising dose to surrounding tissue. IMRT is usually used in head and neck
cancers where many radiosensitive critical organs such as spinal cord, brain stem and parotid
gland are in close proximity to the targets. Sensorineural hearing loss is a common side effect
of radiotherapy in patients with head and neck cancer. The basal turn of cochlea which is
responsible for high frequency hearing sounds is more susceptible for radiation than apical
turn ,which explains radiation causing hearing loss at higher frequency.Sensorineural hearing
loss as a result of Radiotherapy to inner ear and cochlea is a radiation dose limiting toxicity
.Incidence of hearing loss can be minimised by maintaining the optimal cochlear radiation
dose. Hearing tests prior and after radiotherapy enable in understanding dose response in
order to assess the risk and severity of hearing loss. Aim:To determine the effect of cochlear
dose on sensorineural hearing loss in patients with head and neck cancer treated by
radiotherapy. Objectives:To evaluate hearing loss in patients receiving radiotherapy only and
chemoradiation for head and neck malignancies using pure tone audiometry.
To evaluate hearing loss in patients receiving radiotherapy only and chemoradiation for head
and neck malignancies using DPAOE and tympanogram.
To compare hearing loss in patients receiving only radiotherapy and concurrent
chemoradiation.
To detect whether hearing loss is low frequency or high frequency.
To compare sensorineural hearing loss in patients receiving unilateral and bilateral neck
irradiation.

STUDY DESIGN :A Longitudinal Descriptive study
STUDY POPULATION: Patients receiving radiotherapy and chemoradiation for head and
neck cancer

